TQ Quiz | Latest Advances in Eye Care Technology Innovations in Early Detection and Management (Nashville 2025) by Events@optometricedu.com | Oct 22, 2025 | 2025 Nashville, TQ Courses | 0 comments "*" indicates required fields This field is hidden when viewing the formDate (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent Date (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent 90 days past date (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent Date Difference (Hidden)1. What is the primary clinical benefit of OCT Angiography in ocular disease detection?* A - Detecting optic nerve drusen B - Measuring intraocular pressure C - Visualizing retinal pigment epithelium D - Non-invasive visualization of retinal vessels and choroidal vasculature changes 2. Which of the following technologies uses flicker comparison to highlight changes in retinal images over time?* A - Eidon Camera B - Avulux Glasses C - iCare HOME D - OCT Angiography 3. Which parameter measured by the Ocular Response Analyzer (ORA) is an independent risk factor for glaucoma progression?* A - Central corneal thickness B - Intraocular pressure (IOP) C - Anterior chamber depth D - Corneal hysteresis (CH) 4. What feature makes the iCare HOME tonometer unique in glaucoma management?* A - Requires anesthetic B - Air-puff measurement C - Laser-based IOP detection D - Allows at-home (non-office hours) IOP monitoring 5. Which test measures early functional vision decline before VA loss?* A - OCT Angiography B - Eidon TrueColor Imaging C - Optomap widefield imaging D - Rabin Cone Contrast Sensitivity Test 6. What does iDose by Glaukos deliver to treat glaucoma?* A - Travoprost B - Latanoprost C - Dorzolamide HCL D - Brimonidine tartrate 7. Which technology objectively measures carotenoid levels in the body?* A - Avulux Glasses B - OCT Angiography C - Hand and Finger Scanners D - Ocular Response Analyzer (ORA) 8. Which drop is indicated for presbyopia and works via pupil constriction and spares the ciliary body?* A - Aceclidine B - Latanoprost C - Oxervate (cenegermin-bkbj) D - Pavblu (aflibercept-ayyh) 9. Oxervate (cenegermin-bkbj) is used to treat which ocular condition?* A - Uveitis B - Presbyopia C - Dry eye syndrome D - Neurotrophic keratitis 10. What is the mechanism of action of Acoltremon?* A - VEGF inhibition B - Muscarinic receptor antagonist C - Immunosuppressive anti-inflammatory D - Non-immunosuppressive surface healing agent 11. Pavblu (aflibercept-ayyh) is a biosimilar of which anti-VEGF medication?* A - Eylea B - Lucentis C - Bevacizumab D - Brolucizumab 12. What makes CAM 360 different from Prokera?* A - Prokera treats glaucoma B - CAM 360 is an oral supplement C - Prokera has a longer duration D - CAM 360 uses sutureless, full corneal coverage 13. Avulux glasses help patients with which condition?* A - Migraine and photophobia B - Glaucoma C - Cataracts D - Dry eye disease 14. What is the key advantage of Lacrifill (canalicular plug filler) over traditional punctal plugs?* A - Permanent occlusion B - Biodegradable and injectable C - Surgically implanted D - Longer lasting than permanent plug 15. Which of the following monitors diurnal IOP variation at home?* A - Eidon Camera B - iCare HOME C - OCT Angiography D - Ocular Response Analyzer (ORA) 16. Which biologic tear is derived from the patient’s own blood?* A - Oxervate (cenegermin-bkbj) B - CAM 360 C - Cryopreserved amniotic member D - Autologous Serum Eye Drops by Ocubio 17. Which imaging modality offers flicker compassion, widefield TrueColor, and autofluorescence?* A - OCT B - Eidon Camera C - All fundus cameras D - Fluorescein angiography 18. Which visual test may detect neurodegenerative disease before VA is affected?* A - Rabin Cone Contrast Sensitivity Test B - Ocular Response Analyzer (ORA) C - Snellen chart D - Pinhole test 19. Which condition is NOT a primary indication for Pavblu (aflibercept-ayyh)?* A - Diabetic macular edema B - Neovascular AMD C - Neurotrophic keratitis D - Diabetic retinopathy 20. What is the application method for the cryopreserved amniotic membrane (Prokera)?* A - Eye drop B - Oral tablet C - Ring containing amniotic membrane D - Surgical injection Personal InformationName* First Last Email* Phone*OE Tracker #License #Address* Street Address Address Line 2 City State / Province / Region ZIP / Postal Code AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Country Payment InformationPromotional CodeNashville 2025 - Identifying and Managing Pharmaceutical Complications*After 90 days, pricing will increase to $30. Price: Retake Discount Price: Promotional Discount Price: Credit Card* This field is hidden when viewing the formCourse Information (HIDDEN)This field is hidden when viewing the formCourse Name (HIDDEN)This field is hidden when viewing the formRetake Code (HIDDEN)This field is hidden when viewing the formQuiz URL (HIDDEN)Do not include ending backslash (aka no .com/)This field is hidden when viewing the formCE Hours Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website
